SCHEMBL29795449

SCHEMBL29795449

O=C(NCCc1ccccc1)n1cnc2ccccc21

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 10/20 0.83
MAPK1 P28482 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 2/20 0.49
RAB9A P51151 2/20 0.49
CYP1A2 P05177 1/20 0.49
BCHE P06276 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
MAPT P10636 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HTT P42858 1/20 0.49
NPC1 O15118 1/20 0.48
P2RX4 Q99571 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23122842 1.00 ASAH1 (0.83) ASAH1MAPK1SMN1; SMN2LMNAL3MBTL1
SCHEMBL29795398 0.92 ASAH1 (0.93) ASAH1MAPK1SMN1; SMN2LMNAL3MBTL1
SCHEMBL28794797 0.92 ASAH1 (0.93) ASAH1MAPK1SMN1; SMN2LMNAL3MBTL1
SCHEMBL28945621 0.91 ASAH1 (1.00) ASAH1
SCHEMBL29795633 0.91 ASAH1 (1.00) ASAH1
SCHEMBL29795592 0.90 ASAH1 (0.77) ASAH1MAPK1SMN1; SMN2LMNAALDH1A1
SCHEMBL28794776 0.90 ASAH1 (0.77) ASAH1MAPK1SMN1; SMN2LMNAALDH1A1
SCHEMBL29795498 0.87 ASAH1 (0.65) ASAH1MAPK1SMN1; SMN2RAB9ANPC1
SCHEMBL28794578 0.87 ASAH1 (0.65) ASAH1MAPK1SMN1; SMN2RAB9ANPC1
SCHEMBL29795445 0.86 ASAH1 (0.64) ASAH1MAPK1L3MBTL1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4031532-A1 SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed